Loading
Led JULIET, which brought tisagenlecleucel, the first CAR-T, to adults with relapsed large B-cell lymphoma.
Stephen Schuster led the first trial of CTL019 (tisagenlecleucel) in lymphoma and was principal investigator of JULIET, the global trial that won its approval for relapsed or refractory DLBCL, and of the follow-up studies showing durable five-year remissions. He directs the lymphoma programme at Penn and continues to lead trials of next-generation CAR-T and bispecific antibodies.
Shares CD19, Follicular lymphoma, CAR-T cell therapy, Diffuse large B-cell lymphoma and the tags lymphoma, car-t, cell-therapy.
Shares Lymphoma roadmap: from a jaw tumour in Uganda and the first human cancer virus to gene-expression subtypes, PET-adapted chemotherapy, CAR-T cells, bispecific antibodies and the genetics-directed trials now recruiting, Follicular lymphoma and the tags lymphoma, car-t, cell-therapy.
Shares CD19, Lymphoma roadmap: from a jaw tumour in Uganda and the first human cancer virus to gene-expression subtypes, PET-adapted chemotherapy, CAR-T cells, bispecific antibodies and the genetics-directed trials now recruiting, CAR-T cell therapy, Diffuse large B-cell lymphoma and the tags lymphoma, car-t.
Shares Abramson Cancer Center, University of Pennsylvania, CD19, CAR-T cell therapy and the tags car-t, cell-therapy.
Shares CD19, CAR-T cell therapy, Diffuse large B-cell lymphoma and the tags car-t, cell-therapy.
Shares CD19, Lymphoma roadmap: from a jaw tumour in Uganda and the first human cancer virus to gene-expression subtypes, PET-adapted chemotherapy, CAR-T cells, bispecific antibodies and the genetics-directed trials now recruiting, CAR-T cell therapy and the tags lymphoma, car-t.
Shares Lymphoma roadmap: from a jaw tumour in Uganda and the first human cancer virus to gene-expression subtypes, PET-adapted chemotherapy, CAR-T cells, bispecific antibodies and the genetics-directed trials now recruiting, Follicular lymphoma, Diffuse large B-cell lymphoma and the tag lymphoma.
Shares CAR-T cell therapy and the tags car-t, cell-therapy.